Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Metadata
Title
Trovafloxacin
A Viewpoint by Robert C. Moellering Jr
Author
Robert C. Moellering Jr
Publication date
01-09-1997
Publisher
Springer International Publishing
Published in
Drugs / Issue 3/1997
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-199754030-00008

Other articles of this Issue 3/1997

Drugs 3/1997 Go to the issue

Adis Drug Evaluation

Gemcitabine

Review Article

Breast Cancer Therapies in Development

Adis New Drug Profile

Trovafloxacin

Adis New Drug Profile

Trovafloxacin

Leading Article

Drug Treatment of Non-Insulin-Dependent Diabetes Mellitus in the 1990s

Drug Evaluation

Lansoprazole